FDA DEVICE FACTS
Microflex Nitrile Patient Examination Gloves Blue Colored Tested for Use with Chemotherapy Drugs and Fentanyl Citrate, Microflex Nitrile Patient Examination Gloves Green Colored Tested for Use with Chemotherapy Drugs and Fentanyl Citrate, Microflex Nitrile Patient Examination Gloves Black Colored Tested for Use with Chemotherapy Drugs and Fentanyl Citrate
Ansell Healthcare Products, LLC
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
A powder-free patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. The glove was tested for use with Chemotherapy Drugs and Fentanyl Citrate as per ASTM D6978-0S Standard Practice for Assessment for Medical Gloves to Permeation by Chemotherapy Drugs. Please note that the following drug has an extremely low permeation time: Carmustine: 47.9 minutes. Warning: Do not use with Carmustine. Tested chemotherapy drugs are as follows: Test Chemotherapy drug & Concentration Carmustine - 3.3 mg/ml Cyclophosphamide - 20.0 mg/ml Doxorubicin HCI - 2.0 mg/ml Etoposide - 20.0 mg/ml Average Breakthrough Detection Time (Minutes) 47.9 Fentanyl Citrate Injection - 100 mcg/2 ml Fluorouracil - 50.0 mg/ml Methotrexate - 25.0 mg/ml Paclitaxel - 6.0 mg/ml Thiotepa - 10.0 mg/ml Vincristine Sulfate - 1.0 mg/ml A powder-free patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. The glove was tested for use with Chemotherapy Drugs and Fentanyl Citrate as per ASTM D6978-05 Standard Practice for Assessment for Medical Gloves to Permeation by Chemotherapy Drugs. Please note that the following drug has an extremely low permeation time: Carmustine: 49.6 minutes. Warning: Do not use with Carmustine. Tested chemotherapy drugs are as follows: Test Chemotherapy drug & Concentration Carmustine - 3.3 mg/ml Cisplatin - 1.0 mg/ml Cyclophosphamide - 20.0 mg/ml Dacarbazine - 10.0 mg/ml Doxorubicin HCI - 2.0 mg/ml Etoposide- 20.0 mg/ml Average Breakthrough Detection Time (Minutes) 49.6 >240 >240 >240 >240 >240 Fentanyl Citrate Injection - 100 mcg/2 ml Fluorouracil - 50.0 mg/ml >240 >240 Methotrexate - 25.0 mg/ml >240 Paclitaxel - 6.0 mg/ml >240 Thiotepa - I 0.0 mg/ml >240 Vincristine Sulfate - 1.0 mg/ml >240 A powder-free patient examination glove is a disposable device intended for medical purposes that is worn on the examiner's hand to prevent contamination between patient and examiner. The glove was tested for use with Chemotherapy Drugs and Fentanyl Citrate as per ASTM D6978-05 Standard Practice for Assessment for Medical Gloves to Permeation by Chemotherapy Drugs. Please note that the following drug has an extremely low permeation time: Carmustine: 27.6 minutes. Warning: Do not use with Carmustine. Tested chemotherapy drugs are as follows: Test Chemotherapy drug & Concentration Carmustine - 3.3 mg/ml Cyclophosphamide - 20.0 mg/ml Doxorubicin HCI - 2.0 mg/ml Etoposide - 20.0 mg/ml Average Breakthrough Detection Time (Minutes) 27.6 Fentanyl Citrate Injection - 100 mcg/2 ml Fluorouracil - 50.0 mg/ml Methotrexate - 25.0 mg/ml Paclitaxel - 6.0 mg/ml Thiotepa - 10.0 mg/ml Vincristine Sulfate - 1.0 mg/ml
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。